Article List

WPRIM Management System> DCMS> Journal of Korean Diabetes> 2011> 12

Volume: 12

1. Diabetic Foot: Past and Present.	Page:69—71
2. Why Does the MOHW Consider Type 2 Diabetes Mellitus to be a Slight Illness?.	Page:65—68
3. A Case of Type 2 Diabetes Mellitus Improved after Surgical Treatment of Primary Hyperparathyroidism.	Page:60—63
4. Improvement of Type 2 Diabetes after Bariatric Surgery in a Patient with Severe Obesity.	Page:53—59
5. Individualized Diabetes Education.	Page:50—52
6. Nutrition Recommendations for Special Diabetic Situations.	Page:45—49
7. Increaseing Physical Activity in Daily Life.	Page:41—44
8. Exercise in the Elderly with Diabetes.	Page:37—40
9. Exercise in Patients with Advanced Diabetic Complications.	Page:33—36
10. Role of Exercise in Prevention of Type 2 Diabetes.	Page:29—32
11. Effect of Exercise on Cardiovascular Disease in Patients with Diabetes Mellitus (Aerobic vs. Resistance).	Page:25—28
12. Effect of Exercise on Glucose Metabolism.	Page:21—24
13. Epidemiology of Physical Activity Participation and Type 2 Diabetes in Korea.	Page:13—20
14. The Effects of Aerobic/Resistance Exercise on Body Fat Mass, Muscle Strength and Endothelial Function in Korean Type 2 Diabetes mellitus Patients.	Page:6—12
15. Outcome Research in Diabetes.	Page:2—5
16. Food Nutrition Information, Where Can We Get Sources of Nutrition Information in Food?.	Page:163—166
17. Application of Continuous Glucose Monitoring System (CGMS) and Patient Education.	Page:159—162
18. Meal Management for Patients with Type 2 Diabetes Mellitus Undergoing Metabolic Surgery.	Page:154—158
19. Intraoperative and Postoperative Glycemic Management in Patients with Diabetes.	Page:150—153
20. Preoperative Glycemic Control of Surgical Patients with Diabetes.	Page:147—149
21. Preoperative Assessment of Cardiac Risk in the Patient with Diabetes.	Page:142—146
22. Effect of Diabetes in Surgery.	Page:138—141
23. Diabetes Management System Based on Ubiquitous Healthcare.	Page:133—137
24. Clinical Trial for Antidiabetic Drugs: FDA Guidance for Diabetes Mellitus-Evaluation of Cardiovascular Risk in New Antidiabetic Therapies.	Page:129—132
25. Negative-Pressure Wound Therapy Using Modified Vacuum-Assisted Closure in Patients with Diabetic Foot Ulcers.	Page:122—127
26. The Education Effect of Glucometer Use on the Glucose Levels and the Glucose Value Comparison among Diverse Glucometers.	Page:113—121
27. Motivational Interviewing for People with Diabetes Mellitus.	Page:109—112
28. Vitamin D and Diabetes.	Page:104—108
29. Tips for Creating Effective Health Education Materials.	Page:99—103
30. Prevention and Education for Diabetic Foot.	Page:95—98
31. Surgical Treatment of Diabetic Foot Disease.	Page:88—94
32. Antimicrobial Therapy in Diabetic Foot Infections.	Page:83—87
33. Pathogenesis of the Diabetic Foot Disease.	Page:80—82
34. Risk Factors for Foot Ulceration in Diabetic Patients.	Page:76—79
35. Epidemiology of Diabetic Foot Disease.	Page:72—75
36. A Case of Acetone Intoxication Misdiagnosed as Diabetic Ketoacidosis.	Page:245—247
37. Korean Food Exchange Lists for Diabetes: Revised 2010.	Page:228—244
38. The Psychological Response of Diabetes Patients.	Page:225—227
39. Colored Foods and Diabetes.	Page:219—224
40. Lifestyle Modification and Diabetes Management.	Page:215—218
41. Pharmacothearpy of Adolescents with Diabetes.	Page:211—214
42. Drug Therapy of Elderly Diabetic Patients.	Page:205—210
43. Medical Therapy in Pregnant Women with Diabetes.	Page:201—204
44. Treatment Strategy for Diabetes with Cardiovascular Disease.	Page:198—200
45. Oral Antidiabetic Agents in Patients with Chronic Kidney Disease.	Page:194—197
46. Use of Oral Hypoglycemic Agents in Type 2 Diabetic Patients with Hepatic Dysfunction.	Page:190—193
47. 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea.	Page:183—189
48. Satisfaction with High Deductible Policies among Patients with Diabetes in the Korean General/University Hospital System.	Page:179—182
49. A Case of Diabetic Foot Infection due to Leclercia adecarboxylata.	Page:174—177
50. A Case of Gabapentin-induced Myoclonus in a Type 2 Diabetic Patient with End-stage Renal Disease.	Page:171—173
51. Involving Family Members in Diabetes Treatment.	Page:167—170